Iadademstat in Combination With Azacitidine and Venetoclax in Treating Newly Diagnosed Acute Myeloid Leukemia

Clinical trial NCT06357182 · RECRUITING

Trial details

NCT number: NCT06357182
Sponsor: OHSU Knight Cancer Institute
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Myelodysplastic Syndrome/Acute Myeloid Leukemia

Start date: 2024-08-22
Primary completion: 2027-03-08
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.